It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2007.
2007 | New Delhi, Delhi, India | ActiveSwarn Artificial Aids Private Limited, a active private limited company, was established on 29 May 2007 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the healthcare sector, it holds CIN: U93000DL2007PTC164055. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajbala Rani (Director), Satish Kumar Goel (Director). Past directors included Swarna Madhok, Rajinder Kumar Mehta, Kulbhushan Madhok. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at T-2321 Faiz Road, Karol Bagh, New Delhi, Delhi, 110005.
U93000DL2007PTC164055
164055
29 May 2007
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Swarn Artificial Aids Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajbala Rani | Director | 14 Aug 2008 | Current |
| Satish Kumar Goel | Director | 14 Aug 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2011 | Past |
| Pramod Abcsdd | Director | 19 Aug 2008 | Past |
| Pramod Abcsdd | Director | 01 Dec 2011 | Past |
| Pramod Abcsdd | Director | 19 Aug 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Swarn Artificial Aids Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 14.44% increase. The company also saw a substantial improvement in profitability, with a 329.5% increase in profit. The company's net worth Soared by an impressive increase of 14.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Swarn Artificial Aids had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Swarn Artificial Aids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Swarn Artificial Aids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swarn Artificial Aids's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Swarn Artificial Aids Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Swarn Artificial Aids Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Rajbala Rani was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 3 months . was recorded as a recent event.
Progress on Satish Kumar Goel was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 3 months . was documented.
The activity Swarn Artificial Aids Private Limited was registered on 29 May 2007 with Roc Delhi & aged 18 years 6 months as per MCA records. was completed.
The CIN of Swarn Artificial Aids Private Limited is U93000DL2007PTC164055.
Swarn Artificial Aids Private Limited is headquartered at T-2321 Faiz Road, Karol Bagh, New Delhi, Delhi, 110005.
Swarn Artificial Aids Private Limited was incorporated on 29 May 2007.
The current directors of Swarn Artificial Aids Private Limited are
The primary industry of Swarn Artificial Aids Private Limited is Healthcare.
Swarn Artificial Aids Private Limited is unlisted.
The authorized capital of Swarn Artificial Aids Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Swarn Artificial Aids Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX